Similar articles

• Drug metabolism and variability among patients in drug response.

  Wilkinson GR. Wilkinson GR. N Engl J Med. 2005 May 26;352(21):2211-21. doi: 10.1056/NEJMra032424. N Engl J Med. 2005. PMID: 15917386 Review. No abstract available.
• Association of polymorphisms in the cytochrome P450 (CYP) 2C19 and 2C18 genes in Japanese epileptic patients.

  Mamiya K, Ieiri I, Miyahara S, Imai J, Furuumi H, Fukumaki Y, Ninomiya H, Tashiro N, Yamada H, Higuchi S. Mamiya K, et al. Pharmacogenetics. 1998 Feb;8(1):87-90. doi: 10.1097/00008571-199802000-00012. Pharmacogenetics. 1998. PMID: 9511186 No abstract available.
• [Classical pharmacogenetics].

  Brøsen K. Brøsen K. Ugeskr Laeger. 2005 May 16;167(20):2143-6. Ugeskr Laeger. 2005. PMID: 15987068 Danish. No abstract available.
• The structure, function, and regulation of cytochrome P450 2A enzymes.

  Honkakoski P, Negishi M. Honkakoski P, et al. Drug Metab Rev. 1997 Nov;29(4):977-96. doi: 10.3109/03602539709002240. Drug Metab Rev. 1997. PMID: 9421682 Review. No abstract available.
• Phenotyping of drug metabolism in infants and children: potentials and problems.

  Rane A. Rane A. Pediatrics. 1999 Sep;104(3 Pt 2):640-3. Pediatrics. 1999. PMID: 10469807 No abstract available.